![]() |
市場調査レポート
商品コード
1729499
日本のインスリンポンプ市場レポート:製品タイプ、流通チャネル、地域別、2025年~2033年Japan Insulin Pumps Market Report by Product Type (Insulin Pumps, Insulin Pumps Supplies and Accessories), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/Centers, and Others), and Region 2025-2033 |
||||||
カスタマイズ可能
|
日本のインスリンポンプ市場レポート:製品タイプ、流通チャネル、地域別、2025年~2033年 |
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 118 Pages
納期: 5~7営業日
|
日本のインスリンポンプ市場規模は2024年に3億3,120万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに5億4,550万米ドルに達し、2025年から2033年にかけて5.7%の成長率(CAGR)を示すと予測しています。糖尿病有病率の増加、従来のインスリン注射よりもインスリンポンプへの嗜好の高まり、急速な技術進歩、高齢者人口の増加、研究開発活動への注力強化などが市場を牽引する主な要因です。
The Japan insulin pumps market size reached USD 331.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 545.5 Million by 2033, exhibiting a growth rate (CAGR) of 5.7% during 2025-2033. The increasing prevalence of diabetes, the rising preference for insulin pumps over traditional insulin injections, rapid technological advancements, increasing geriatric population, and enhanced focus on research and development (R&D) activities represent some of the key factors driving the market.
Insulin pumps are small electronic devices that deliver insulin to individuals with diabetes. They are typically worn externally, either on a belt or in a pocket, and are connected to the body through a thin tube called an infusion set. The pump delivers insulin continuously, mimicking the function of a healthy pancreas. As compared to traditional insulin injections, insulin pumps offer a more flexible and precise way of administering insulin. They can deliver both basal insulin, which is a small amount of insulin continuously released to control blood sugar levels between meals and during sleep, as well as bolus insulin, which is a larger dose of insulin taken before meals to cover the rise in blood sugar after eating.
One of the major factors driving the Japan insulin pumps market is the increasing prevalence of diabetes. Insulin pumps offer greater convenience, flexibility, and precision in insulin delivery and help improve blood sugar control, reduce hypoglycemia (low blood sugar) episodes, and enhance the overall quality of life for many individuals with diabetes. In line with this, the rising preference for insulin pumps over traditional insulin injections due to the convenience and lifestyle benefits they offer is acting as another growth-inducing factor. Moreover, the implementation of various initiatives by the Japanese government to provide coverage for various medical treatments, including diabetes management, is creating a positive outlook for the market. Apart from this, continuous technological advancements in insulin pumps, such as the development of smart pumps with integrated continuous glucose monitoring (CGM) systems that offer improved accuracy, ease of use, and better glycemic control for patients is providing a considerable boost to the market growth. Furthermore, the increasing awareness about the benefits of insulin pumps and proper diabetes management among the masses is propelling the market growth. Additionally, the growing trend toward minimally invasive (MI) medical technologies aligns with the appeal of insulin pumps, which involve needle insertion only during the infusion set change is contributing to the market growth. Other factors, including significant growth in the healthcare industry, rising expenditure capacities of consumers, rapid technological advancements, increasing geriatric population, enhanced focus on research and development (R&D) activities, and growing demand for effective and convenient diabetes management solutions, are presenting remunerative growth opportunities for the market.